Edoxaban tosylate is a direct oral anticoagulant that functions as a selective factor Xa inhibitor, widely indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial… Read more
Edoxaban tosylate is a direct oral anticoagulant that functions as a selective factor Xa inhibitor, widely indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as the treatment of venous thromboembolism. This category features reference standards for edoxaban tosylate, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential tools for pharmaceutical laboratories engaged in rigorous analytical testing, method validation, and quality control of the active pharmaceutical ingredient. By utilizing these precise compounds, researchers can ensure accurate impurity profiling and reliable identification of degradation products throughout the drug development lifecycle. Stable isotope labelled standards are particularly valuable for tracing metabolic pathways and ensuring data precision in mass spectrometry applications, ultimately supporting compliance with regulatory standards for safety and efficacy in the development of modern anticoagulant therapies.